Kaken Pharmaceutical Co Ltd

4521

Company Profile

  • Business description

    Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

  • Contact

    28-8, Honkomagome 2-chome
    Bunkyo-ku
    Tokyo1138650
    JPN

    T: +81 359775001

    http://www.kaken.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    1,297

Stocks News & Analysis

stocks

Wildly overvalued ASX stock is skating on thin ice

This company dominates its industry and could be flirting with regulatory intervention.
stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.009.10-0.10%
CAC 407,709.3274.290.97%
DAX 4024,192.50268.141.12%
Dow JONES (US)43,968.64224.48-0.51%
FTSE 1009,100.7763.54-0.69%
HKSE25,081.63171.000.69%
NASDAQ21,242.7073.270.35%
Nikkei 22541,059.15264.290.65%
NZX 50 Index12,887.106.940.05%
S&P 5006,340.005.06-0.08%
S&P/ASX 2008,831.4012.30-0.14%
SSE Composite Index3,639.675.670.16%

Market Movers